Metformina Sandoz

Metformin, the active ingredient in Metformina Sandoz, is a Biguanide presented as a unknown/unknown for oral use. It treats type 2 diabetes mellitus in adults by improving blood glucose control. GNH USA supplies Metformina Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformina Sandoz is a biguanide antidiabetic used to manage hyperglycaemia in the type 2 diabetes mellitus pathway. - Type 2 diabetes mellitus: improves glycaemic control by lowering fasting and post‑prandial blood glucose levels.

Metformina Sandoz may cause a range of adverse reactions. Patients should be aware of both frequent and rare events.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhoea: loose stools, often transient. - Abdominal discomfort: cramping or pain. - Metallic taste: altered taste perception. - Weight loss: modest reduction in body weight. - Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: especially when combined with insulin or sulfonylureas. - Hepatic dysfunction: elevated liver enzymes or hepatitis. - Allergic skin reactions: rash, urticaria, or Stevens‑Johnson syndrome. - Pancreatitis: inflammation of the pancreas. - Electrolyte disturbances: especially with concomitant diuretics.

Before initiating Metformina Sandoz, clinicians should evaluate patient‑specific risk factors and monitor therapy. - Renal function assessment: check eGFR and adjust or avoid use in severe renal impairment. - Lactic acidosis risk: avoid in patients with significant hepatic disease, heart failure, or hypoxia. - Alcohol consumption: limit intake to reduce acidosis risk. - Pregnancy and lactation: use only if potential benefit justifies potential risk. - Drug interactions: review concomitant medicines for possible interactions. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformina Sandoz can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate lactic acidosis; discontinue before imaging. - Cimetidine: can increase metformin plasma concentrations. - Nitrates: combined use may cause severe hypotension.

Moderate Interactions (Monitor Closely): - Beta‑blockers: increase risk of hypoglycaemia; monitor glucose levels. - Thiazide diuretics: may affect renal function and electrolytes; assess regularly. - ACE inhibitors/ARBs: monitor renal function and serum creatinine.